# Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

> **NCT00219349** · PHASE4 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 25 (actual)

## Conditions studied

- Generalized Anxiety Disorder

## Interventions

- **BEHAVIORAL:** Cognitive Behavioral Therapy
- **DRUG:** escitalopram

## Key facts

- **NCT ID:** NCT00219349
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-01
- **Primary completion:** 2008-07
- **Final completion:** 2008-07
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2017-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00219349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00219349, "Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00219349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*